Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 8, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 7
| |||||||
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 2
| |||||||
Sana Biotechnology, Inc.
| -334.00K |
—
|
—
| -4.09% | 7.84M |
Apr 14
| |||||||
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 3
| |||||||
Sana Biotechnology, Inc.
| 2.03M |
—
|
—
| +33.07% | 8.17M |
Feb 8
| |||||||
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 15
| |||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Juno Therapeutics, Inc.
| -639.52K |
$87.00 |
—
| -100.00% |
0
| +1 |
Mar 5
| ||||||
Juno Therapeutics, Inc.
| 11.54K |
—
|
—
| +1.84% | 639.52K | +1 |
Feb 27
| ||||||
Juno Therapeutics, Inc.
| -164.49K |
$85.49 | -$145,674.96 | -20.76% | 627.97K | +1 |
Feb 7
| ||||||
Juno Therapeutics, Inc.
| 29.14K |
—
|
—
| +3.82% | 792.47K | +1 |
Jan 31
| ||||||
Juno Therapeutics, Inc.
|
0
|
$26.74 | -$315,373.72 |
—
| 763.33K | +1 |
Dec 21
|
Scheduled
| |||||
Juno Therapeutics, Inc.
| 35.89K |
—
|
—
| +4.93% | 763.33K | +1 |
Oct 20
| ||||||
Juno Therapeutics, Inc.
|
0
|
$19.36 | -$186,200.00 |
—
| 727.44K | +1 |
Jul 3
|
Scheduled
| |||||
Juno Therapeutics, Inc.
|
0
|
$19.36 | -$186,200.87 |
—
| 727.44K | +1 |
Jun 27
|
Scheduled
| |||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Juno Therapeutics, Inc.
| 27.44K |
—
|
—
| +3.92% | 727.44K | +1 |
Feb 7
| ||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 7
| |||||||
Loxo Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Juno Therapeutics, Inc.
| -30.00K |
$43.32 | -$1,299,529.65 | -4.11% | 700K | +1 |
Jun 10
|
Scheduled
| |||||
Juno Therapeutics, Inc.
| -5.00K |
$45.00 | -$225,000.00 | -0.68% | 730K |
Mar 4
|
Scheduled
| ||||||
Juno Therapeutics, Inc.
| -30.00K |
$37.58 | -$1,127,341.65 | -3.92% | 735K |
Mar 1
|
Scheduled
| ||||||
Juno Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 2
| |||||||
Juno Therapeutics, Inc.
| -35.00K |
$46.43 | -$1,625,074.16 | -4.38% | 765K |
Dec 10
|
Scheduled
| ||||||
Juno Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 3
| |||||||
Juno Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 3
| |||||||
Juno Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.